Evidence map›Paper›PMID 34463618›Full record

ArticleeLife2021

Inducible and reversible inhibition of miRNA-mediated gene repression in vivo.

Gaspare La Rocca, Bryan King, Bing Shui, Xiaoyi Li, Minsi Zhang, Kemal M Akat, Paul Ogrodowski, Chiara Mastroleo, Kevin Chen, Vincenzo Cavalieri and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. miRNA modules for precise, tunable control of gene expression.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. [Research advances on the role and mechanism of microRNA in hypertrophic scar].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023
    Article
  18. Article
  19. The Multiplicity of Argonaute Complexes in Mammalian Cells.The Journal of pharmacology and experimental therapeutics · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 6 countries.

Gaspare La Rocca *Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.ORCID 0000-0003-1277-0566
Bryan King *Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Bing ShuiDepartment of Cancer Biology, Dana Farber Cancer Institute, Boston, United States.ORCID 0000-0002-5956-130X
Xiaoyi LiCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Minsi ZhangCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Kemal M AkatLaboratory of RNA Molecular Biology, The Rockefeller University, New York, United States.ORCID 0000-0002-9012-3551
Paul OgrodowskiCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Chiara MastroleoCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Kevin ChenCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.ORCID 0000-0002-0674-1411
Vincenzo CavalieriDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, Italy.
Yilun MaWeill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, New York, United States.
Viviana AnelliCenter of Integrative Biology, University of Trento, Trento, Italy.
Doron BetelHem/Oncology, Medicine and Institution for Computational Biomedicine, Weill Cornell Medical College, New York, United States.
Joana VidigalLaboratory of Biochemistry and Molecular Biology, National Cancer Institute, Bethesda, United States.
Thomas TuschlLaboratory of RNA Molecular Biology, The Rockefeller University, New York, United States.
Gunter MeisterRegensburg Center for Biochemistry, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-2098-9923
Craig B ThompsonCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.ORCID 0000-0003-3580-2751
Tullia LindstenImmunology Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Kevin HaigisDepartment of Cancer Biology, Dana Farber Cancer Institute, Boston, United States.
Andrea VenturaCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, United States.ORCID 0000-0003-4320-9907
Memorial Sloan Kettering Cancer Center · USCornell University · USDana-Farber Cancer Institute · USRockefeller University · USNational Cancer Institute · USNational Institutes of Health · USUniversity of Palermo · ARUniversity of Regensburg · DEUniversity of Trento · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
MSK Paul Calabresi Career Development Award for Clinical OncologyK12CA184746 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Omar Abdel-Wahab, Simon N. Powell · 2015 to 2026
$8.3M
Investigating the functions of the miR-17~92 family of oncogenic microRNA clustersR01CA149707 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI VENTURA, ANDREA · 2010 to 2021
$3.8M
Investigating microRNA Function in Homeostasis, Regeneration and CancerR01CA245507 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI VENTURA, ANDREA · 2020 to 2024
$2.6M
NCI NIH HHS K12 CA184746NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA149707NCI NIH HHS R01 CA245507NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Although virtually all gene networks are predicted to be controlled by miRNAs, the contribution of this important layer of gene regulation to tissue homeostasis in adult animals remains unclear. Gain and loss-of-function experiments have provided key insights into the specific function of individual miRNAs, but effective genetic tools to study the functional consequences of global inhibition of miRNA activity in vivo are lacking. Here we report the generation and characterization of a genetically engineered mouse strain in which miRNA-mediated gene repression can be reversibly inhibited without affecting miRNA biogenesis or abundance. We demonstrate the usefulness of this strategy by investigating the consequences of acute inhibition of miRNA function in adult animals. We find that different tissues and organs respond differently to global loss of miRNA function. While miRNA-mediated gene repression is essential for the homeostasis of the heart and the skeletal muscle, it is largely dispensable in the majority of other organs. Even in tissues where it is not required for homeostasis, such as the intestine and hematopoietic system, miRNA activity can become essential during regeneration following acute injury. These data support a model where many metazoan tissues primarily rely on miRNA function to respond to potentially pathogenic events.

Indexed as

Gene Regulatory NetworksAnimalsFemaleHomeostasisMiceMice, TransgenicMicroRNAsPeptidesPregnancyRegenerationRNA-Induced Silencing ComplexTransgenesMicroRNAsPeptidesRNA-Induced Silencing Complexargonautecell biologymicroRNAmiRISCmouseregenerative medicineRISCstem cellsT6BTNRC6

Identifiers

PMID34463618
PMCPMC8476124
OpenAlexW3198759991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.